Beta Bionics annual revenue
2022
2023
2024
2025
Beta Bionics Revenue Growth & History (BBNX)
Beta Bionics reported $100.3M in revenue for fiscal 2025, an increase of 53.94% from the previous fiscal year.
View full Beta Bionics company overviewBeta Bionics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $100.3M | $35.1M | +53.94% |
| 2024 | 2024-12-31 | $65.1M | $53.1M | +442.93% |
| 2023 | 2023-12-31 | $12.0M | $11.8M | +6601.12% |
| 2022 | 2022-12-31 | $179,000 | — | — |
Beta Bionics quarterly revenue
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $32.0M | $8.8M | +37.76% |
| Q1 2026 | 2026-03-31 | $27.6M | $10.0M | +56.62% |
| Q4 2025 | 2025-12-31 | $32.1M | $11.7M | +57.15% |
| Q3 2025 | 2025-09-30 | $27.3M | $10.5M | +63.14% |
| Q2 2025 | 2025-06-30 | $23.2M | $8.2M | +54.45% |
| Q1 2025 | 2025-03-31 | $17.6M | $4.7M | +36.39% |
| Q4 2024 | 2024-12-31 | $20.4M | — | — |
| Q3 2024 | 2024-09-30 | $16.7M | — | — |
| Q2 2024 | 2024-06-30 | $15.0M | — | — |
| Q1 2024 | 2024-03-31 | $12.9M | — | — |
Beta Bionics revenue growth trends
Beta Bionics's latest reported quarter, Q2 2026, generated $32.0M in revenue, an increase of 37.76% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Beta Bionics source filings ↗Community posts
Beta Bionics prices $150 million equity and warrant offering
Beta Bionics ($BBNX) priced a public offering expected to raise approximately $150 million before fees and expenses. The financing includes 7,652,175 common shares at $17.25 each and pre-funded warrants covering another 1,043,484 shares. Un ...
